Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapy crawled date : 2021 - 10 - 04 save search
Selecta Biosciences Announces Strategic Licensing Agreement with Takeda to Develop Next-Generation Gene Therapies for Patients with Lysosomal Storage Disorders
Published: 2021-10-04 (Crawled : 20:00) - biospace.com/
TAK | $13.15 -0.61% 0.0% 1.6M
|
Health Technology
|
| O: -0.28%
H: 0.49%
C: -1.16%
SELB M | $0.8812 -8.0% 2.12% 0
|
Health Technology
|
| O: 0.24%
H: 4.53%
C: 0.95%
gene therapies gene therapy license therapy
Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 36th Anniversary Annual Meeting
Published: 2021-10-04 (Crawled : 14:00) - biospace.com/
CUE | $1.63 9.03% 8.28% 320K
|
Health Technology
|
| O: -1.16%
H: 0.42%
C: -9.97%
presentation immunotherapy biopharma therapy cancer
Candel Therapeutics Announces Participation in Upcoming Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting
Published: 2021-10-04 (Crawled : 14:00) - biospace.com/
CADL | $5.44 -7.64% -8.57% 820K
|
|
| O: -0.48%
H: 2.4%
C: -5.36%
immunotherapy therapy cancer
Turning Point Therapeutics Granted Breakthrough Therapy Designation for Repotrectinib Treatment in Patients with NTRK-Positive, TKI-Pretreated Advanced Solid Tumors
Published: 2021-10-04 (Crawled : 13:15) - globenewswire.com
TPTX | $76.01 -0.03%
|
Health Technology
|
| O: -0.53%
H: 2.39%
C: -0.01%
treatment solid tumors positive therapy breakthrough therapy granted grant designation
UPDATE: Sio Gene Therapies to Present New Data at the European Society of Gene and Cell Therapy Virtual Congress 2021
Published: 2021-10-04 (Crawled : 13:15) - globenewswire.com
SIOX | $0.478 -20.5% 40K
|
Health Technology
|
| O: 5.58%
H: 6.02%
C: 0.88%
europe gene therapies therapy gene therapy
Zai Lab Partner Turning Point Therapeutics Granted Breakthrough Therapy Designation for Repotrectinib Treatment in Patients With NTRK-Positive, TKI-Pretreated Advanced Solid Tumors
Published: 2021-10-04 (Crawled : 13:15) - globenewswire.com
ZLAB | $13.75 -4.65% -4.87% 400K
|
Health Technology
|
| O: -4.58%
H: 2.65%
C: 0.49%
TPTX | $76.01 -0.03%
|
Health Technology
|
| O: -0.53%
H: 2.39%
C: -0.01%
treatment solid tumors positive therapy breakthrough therapy granted designation
National Cancer Institute Selects ImmunityBio’s N-803 IL-15 Receptor Agonist to Combine with Keytruda in 700-Site Lung-MAP Clinical Trial of a Chemo-Free Therapy
Published: 2021-10-04 (Crawled : 13:00) - biospace.com/
IBRX | $5.24 6.5% 6.29% 4.8M
|
Manufacturing
|
| O: 1.31%
H: 2.69%
C: -1.89%
therapy cancer trial keytruda
NeuroStar® Advanced Therapy Recognizes National Depression Education and Awareness Month With New Campaign Launch
Published: 2021-10-04 (Crawled : 13:00) - globenewswire.com
STIM | $3.97 -1.73% -1.76% 24K
|
Health Technology
|
| O: -1.06%
H: 0.0%
C: -3.37%
education therapy depression
FDA Grants Orphan Drug Designation (ODD) to AlloVir’s Posoleucel, an Allogeneic, Off-the-Shelf, Multi-Virus Specific T-Cell Therapy, for the Treatment of Virus-Associated Hemorrhagic Cystitis
Published: 2021-10-04 (Crawled : 12:00) - biospace.com/
ALVR | $0.7569 2.99% 2.29% 570K
|
Health Technology
|
| O: 6.01%
H: 0.0%
C: -13.5%
treatment fda orphan drug therapy drug t-cell tollovir designation
Sio Gene Therapies to Present New Data at the European Society of Gene and Cell Therapy Virtual Congress 2021
Published: 2021-10-04 (Crawled : 12:00) - globenewswire.com
SIOX | $0.478 -20.5% 40K
|
Health Technology
|
| O: 5.58%
H: 6.02%
C: 0.88%
europe gene therapies therapy gene therapy
Zai Lab and Novocure Announce Last Patient Enrolled in Phase 2 Pilot Trial of Tumor Treating Fields Plus Chemotherapy as First-Line Treatment in Gastric Cancer in China
Published: 2021-10-04 (Crawled : 12:00) - globenewswire.com
ZLAB | $13.75 -4.65% -4.87% 400K
|
Health Technology
|
| O: -4.58%
H: 2.65%
C: 0.49%
NVCR | $12.04 -3.37% -3.49% 1.4M
|
Health Technology
|
| O: -1.34%
H: 0.07%
C: -5.6%
treatment phase 2 china therapy cancer trial enroll
Novocure and Zai Lab Announce Last Patient Enrolled in Phase 2 Pilot Trial of Tumor Treating Fields Plus Chemotherapy as First-Line Treatment in Gastric Cancer in China
Published: 2021-10-04 (Crawled : 12:00) - biospace.com/
ZLAB | $13.75 -4.65% -4.87% 400K
|
Health Technology
|
| O: -4.58%
H: 2.65%
C: 0.49%
NVCR | $12.04 -3.37% -3.49% 1.4M
|
Health Technology
|
| O: -1.34%
H: 0.07%
C: -5.6%
treatment phase 2 china therapy cancer trial enroll
SQZ Biotechnologies to Present New Data at the Society for Immunotherapy of Cancer Annual Meeting
Published: 2021-10-04 (Crawled : 11:00) - biospace.com/
SQZ | $0.435 0.0% 30M
|
Health Technology
|
| O: 0.82%
H: 0.94%
C: -10.32%
immunotherapy therapy cancer biotech iot
Gainers vs Losers
| 57% | 43% |
Top 10 Gainers
INVO | $1.82 139.47% 56.82% 220M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.66 46.37% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 600K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.3442 18.28% 23.42% 290K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.